DSM : DSM soft on sales, Firmenich strong; no guidance before 2 August
>DSM EBITDA roughly in line with css, Firmenich strong - DSM EBITDA came in roughly in with css, with 1Q23 sales materially softer (-7% lfl), with DSM highlighting volume rationalisation in a difficult vitamin-context. As such, 1Q23 EBITDA margins sequentially improved (4Q22 was margin trough), where we do highlight relatively soft sales across the board. DSM does not foresee a significant improvement in 2Q23 regarding vitamin A prices, but highlights (in line with pr...Royal DSM is engaged in the creation of products and services in Life Sciences and Materials Sciences. Co.'s products and services are used globally in range of markets and applications in healthcare, pharmaceutical automotive and chemicals sectors. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. The activities of Co. are grouped into four clusters: Nutrition, Pharma, Performance Materials and Polymer Intermediates.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.